(Q30476899)

English

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 October 2017

1 reference

based on heuristic

inferred from title

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome (English)

1 reference

Europe PubMed Central

12 October 2017

Marfan syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pediatric Heart Network Investigators

19

object named as

Pediatric Heart Network Investigators

1 reference

Europe PubMed Central

12 October 2017

Richard B Devereux

6

object named as

Richard B Devereux

1 reference

Europe PubMed Central

12 October 2017

5

object named as

Steven D Colan

1 reference

Europe PubMed Central

12 October 2017

18

object named as

Lynn Mahony

1 reference

Europe PubMed Central

12 October 2017

12

object named as

Beth F Printz

1 reference

Europe PubMed Central

12 October 2017

author name string

Ronald V Lacro

1

1 reference

Europe PubMed Central

12 October 2017

Harry C Dietz

2

1 reference

Europe PubMed Central

12 October 2017

Lisa M Wruck

3

1 reference

Europe PubMed Central

12 October 2017

Timothy J Bradley

4

1 reference

Europe PubMed Central

12 October 2017

Gloria L Klein

7

1 reference

Europe PubMed Central

12 October 2017

Jennifer S Li

8

1 reference

Europe PubMed Central

12 October 2017

L LuAnn Minich

9

1 reference

Europe PubMed Central

12 October 2017

Stephen M Paridon

10

1 reference

Europe PubMed Central

12 October 2017

Gail D Pearson

11

1 reference

Europe PubMed Central

12 October 2017

Reed E Pyeritz

13

1 reference

Europe PubMed Central

12 October 2017

Elizabeth Radojewski

14

1 reference

Europe PubMed Central

12 October 2017

Mary J Roman

15

1 reference

Europe PubMed Central

12 October 2017

J Philip Saul

16

1 reference

Europe PubMed Central

12 October 2017

Mario P Stylianou

17

1 reference

Europe PubMed Central

12 October 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

12 October 2017

American Heart Journal

1 reference

Europe PubMed Central

12 October 2017

154

1 reference

Europe PubMed Central

12 October 2017

4

1 reference

Europe PubMed Central

12 October 2017

624-631

1 reference

Europe PubMed Central

12 October 2017

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Marfan's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Management of Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Regulation and regulatory activities of transforming growth factor beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Marfan Database (third edition): new mutations and new routines for the software

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Latent transforming growth factor-beta: structural features and mechanisms of activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Revised diagnostic criteria for the Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Relationship between blood level of atenolol and pharmacologic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

20 June 2018

Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

28 July 2018

Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

26 November 2018

Codistribution analysis of elastin and related fibrillar proteins in early vertebrate development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

26 November 2018

Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

26 November 2018

Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

26 November 2018

Life expectancy in the Marfan syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042860

26 November 2018

Replacement of the aortic root in patients with Marfan's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17892982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17892982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth and maturation in Marfan syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17892982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17892982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.AHJ.2007.06.024

1 reference

Europe PubMed Central

12 October 2017

1 reference

Europe PubMed Central

12 October 2017

1 reference

Europe PubMed Central

12 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30476899&oldid=2004933600"